ProfileGDS5678 / 1451257_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 15% 15% 15% 14% 14% 15% 16% 14% 14% 15% 15% 14% 14% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3900415
GSM967853U87-EV human glioblastoma xenograft - Control 22.3620515
GSM967854U87-EV human glioblastoma xenograft - Control 32.3613215
GSM967855U87-EV human glioblastoma xenograft - Control 42.3070114
GSM967856U87-EV human glioblastoma xenograft - Control 52.3040914
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4196215
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4120116
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3370214
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3313514
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.349815
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.347815
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3293514
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3551514
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3532115